Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |